MNPR - Monopar Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MNPR is currently covered by 4 analysts with an average price target of $30.15. This is a potential upside of $13.27 (78.61%) from yesterday's end of day stock price of $16.88.

Monopar Therapeutics's activity chart (see below) currently has 6 price targets and 14 ratings on display. The stock rating distribution of MNPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 38.89% with an average time for these price targets to be met of 209.33 days.

Highest price target for MNPR is $10, Lowest price target is $6, average price target is $30.15.

Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 14-Aug-2024. First documented stock forecast 03-Feb-2020.

Best performing analysts who are covering MNPR - Monopar Therapeutics:

Sean Lee Jason Mccarthy Soumit Roy

Currently out of the existing stock ratings of MNPR, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$-8.63 (-58.99%)

$10

2 months 26 days ago
(14-Aug-2024)

5/6 (83.33%)

$3.72 (163.16%)

432

Buy

$10

$-4.63 (-31.65%)

$200

6 months 29 days ago
(11-Apr-2024)

1/3 (33.33%)

$6.15 (159.74%)

196

Buy

$55

1 years 7 months 11 days ago
(29-Mar-2023)

0/1 (0%)

$29.95 (119.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MNPR (Monopar Therapeutics) average time for price targets to be met?

On average it took 209.33 days on average for the stock forecasts to be realized with a an average price target met ratio 38.89

Which analyst has the current highest performing score on MNPR (Monopar Therapeutics) with a proven track record?

SEAN LEE

Which analyst has the current lower performing score on MNPR (Monopar Therapeutics) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on MNPR (Monopar Therapeutics)?

Sean Lee has 6 price targets and 4 ratings on MNPR

Which analyst is the currently most bullish on MNPR (Monopar Therapeutics)?

Jason Mccarthy with highest potential upside - $0

Which analyst is the currently most reserved on MNPR (Monopar Therapeutics)?

Sean Lee with lowest potential downside - -$8.63

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?